Covington Capital Management - INMUNE BIO INC ownership

INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 41 filers reported holding INMUNE BIO INC in Q3 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
Covington Capital Management ownership history of INMUNE BIO INC
ValueSharesWeighting
Q3 2022$6,000
-33.3%
1,0000.0%0.00%
Q2 2022$9,000
+12.5%
1,0000.0%0.00%
Q1 2022$8,000
-20.0%
1,0000.0%0.00%
Q4 2021$10,000
-47.4%
1,0000.0%0.00%
-100.0%
Q3 2021$19,000
+5.6%
1,0000.0%0.00%0.0%
Q2 2021$18,000
+50.0%
1,0000.0%0.00%0.0%
Q1 2021$12,000
-29.4%
1,0000.0%0.00%0.0%
Q4 2020$17,000
+70.0%
1,0000.0%0.00%
Q3 2020$10,000
+100.0%
1,0000.0%0.00%
Q2 2020$5,000
+66.7%
1,0000.0%0.00%
Q1 2020$3,000
-50.0%
1,0000.0%0.00%
Q4 2019$6,0000.0%1,0000.0%0.00%
Q3 2019$6,0001,0000.00%
Other shareholders
INMUNE BIO INC shareholders Q3 2021
NameSharesValueWeighting ↓
Rhenman & Partners Asset Management AB 178,284$1,219,4630.13%
Fermata Advisors, LLC 56,702$383,8880.11%
Westside Investment Management, Inc. 41,540$281,2270.08%
QUADRANT CAPITAL GROUP LLC 60,000$406,2000.04%
MAI Capital Management 97,410$659,4660.01%
Janney Montgomery Scott LLC 256,887$1,7390.01%
Financial Advocates Investment Management 11,510$78,3200.01%
VALLEY NATIONAL ADVISERS INC 1,000$70.00%
Beacon Pointe Advisors, LLC 10,368$70,1910.00%
Asset Dedication, LLC 814$60.00%
View complete list of INMUNE BIO INC shareholders